Attached files
| file | filename |
|---|---|
| 10-K - 10-K - OptiNose, Inc. | optn-20191231.htm |
| EX-32.2 - EX-32.2 - OptiNose, Inc. | optn12-31x201910xkex32.htm |
| EX-32.1 - EX-32.1 - OptiNose, Inc. | optn12-31x201910xkex321.htm |
| EX-31.2 - EX-31.2 - OptiNose, Inc. | optn12-31x201910xkex312.htm |
| EX-31.1 - EX-31.1 - OptiNose, Inc. | optn12-31x201910xkex311.htm |
| EX-21.1 - EX-21.1 - OptiNose, Inc. | listofsubsidiariesex211.htm |
| EX-10.1 - EX-10.1 - OptiNose, Inc. | formindemnificationagr.htm |
| EX-4.7 - EX-4.7 - OptiNose, Inc. | descriptionofsecuritie.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1)Registration Statement (Form S-8 No. 333-221047) pertaining to the Amended and Restated 2010 Stock Incentive Plan and the 2017 Employee Stock Purchase Plan of OptiNose, Inc.
(2)Registration Statement (Form S-8 No. 333-223617) pertaining to the Amended and Restated 2010 Stock Incentive Plan and the 2017 Employee Stock Purchase Plan of OptiNose, Inc.
(3)Registration Statement (Form S-8 No. 333-230083) pertaining to the Amended and Restated 2010 Stock Incentive Plan and the 2017 Employee Stock Purchase Plan of OptiNose, Inc.
(4)Registration Statement (Form S-3 No. 333-228122) of OptiNose, Inc.
of our report dated March 5, 2020, with respect to the consolidated financial statements of OptiNose, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2019.
/s/ Ernst & Young LLP
Philadelphia, Pennsylvania
March 5, 2020